van Vloten W A, Willemze R
Dermatol Clin. 1985 Oct;3(4):665-72.
The prognosis of mycosis fungoides and Sézary syndrome can be improved when antitumor therapies such as total skin electron beam irradiation, topical nitrogen mustard, or systemic cytostatic agents are given as soon as the diagnosis is established. However, differentiation of early lesions of mycosis fungoides and Sézary syndrome from chronic benign dermatoses remains very difficult. To aid in the differential diagnosis, more objective techniques have been developed, including DNA cytophotometry, chromosome analysis, quantitative electron microscopy, and monoclonal antibody staining. Using these methods, skin infiltrates and lymph nodes can be classified more precisely as malignant or benign at an earlier stage of the disease. It must be stressed that these methods can be used only in conjunction with other clinical and histomorphologic criteria. They should never be used alone, however, because reactive processes may sometimes cause problems in interpreting the results.
蕈样肉芽肿和 Sézary 综合征一旦确诊即给予抗肿瘤治疗,如全身皮肤电子束照射、外用氮芥或全身细胞抑制剂,其预后可得到改善。然而,将蕈样肉芽肿和 Sézary 综合征的早期病变与慢性良性皮肤病区分开来仍然非常困难。为了辅助鉴别诊断,已开发出更客观的技术,包括 DNA 细胞光度测定法、染色体分析、定量电子显微镜检查和单克隆抗体染色。使用这些方法,在疾病的早期阶段,皮肤浸润和淋巴结可以更准确地分类为恶性或良性。必须强调的是,这些方法只能与其他临床和组织形态学标准结合使用。然而,它们绝不能单独使用,因为反应性过程有时可能会在解释结果时造成问题。